[{"Assets_0_Q1_USD":"46919300000.0","CIK":"59478","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"2.11","EarningsPerShareDiluted_1_Q1_USD":"2.1","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q1_USD":"131200000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"2499200000.0","NetIncomeLoss_1_Q1_USD":"1902900000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_1_Q1_USD":"885500000.0","ProfitLoss_1_Q1_USD":"1902900000.0","RevenuesConverted_1_Q1_USD":"751500000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"9369400000.0","StockholdersEquity_0_Q1_USD":"9330800000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"906400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"903700000.0","filed":"20220429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"ELI LILLY & CO","period":"20220331","qtrs":"1","uom":"USD"}]